Enzymatic Oligonucleotide Synthesis

Enzymatic oligonucleotide synthesis (EOS) provides an affordable, biological alternative for manufacturing DNA and RNA oligonucleotides used in therapeutics, diagnostics, R&D reagents, and even data storage.  

Addressing the growing demand for sustainable and cost-effective manufacturing, our EOS process uses specifically engineered DNA polymerases that add natural nucleotides sequentially to DNA, critically eliminates de-blocking steps, and reduces oligonucleotide damage.